Skip to main content
Retour
Watch Compare

Shuttle Pharmaceuticals Holdings, Inc.

Qualité des données : 83%
SHPH
Nasdaq Manufacturing Chemicals
0,73 €
▼ 0,03 € (-3,33%)
Cap. Boursière: 4,05 M
Prix
0,73 €
Cap. Boursière
4,05 M
Fourchette du Jour
0,70 € — 0,73 €
Fourchette 52 Semaines
0,50 € — 12,45 €
Volume
33 713
Ouverture 0,70 €
Moyenne 50J / 200J
1,19 €
38,84% below
Moyenne 50J / 200J
2,58 €
71,93% below

Quick Summary

Points Clés

Negative free cash flow of -9,48 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-468,90%
En dessous de la moyenne du secteur (-53,41%)
ROIC-349,35%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,66
Interest CoverageN/A

Valorisation

PE (TTM)
-0,35
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio2,91
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B 2,9 1,6
ROE % -468,9 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11,72 M
ROE -468,90% ROA -259,12%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -9,48 M
ROIC -349,35% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,66
Interest Coverage N/A Asset Turnover N/A
Working Capital 1,30 M Tangible Book Value 1,39 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,35 Forward P/E N/A
P/B Ratio 2,91 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -233,87%
Market Cap 4,05 M Enterprise Value 1,96 M
Per Share
EPS (Diluted TTM) -7,16 Revenue / Share N/A
FCF / Share -1,70 OCF / Share -1,70
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80,89%
SBC-Adj. FCF -10,27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -11,72 M -9,14 M -6,59 M -3,03 M
EPS (Diluted) -7,16 -3,30 -0,44 —
Gross Profit — — — —
Operating Income -11,92 M -7,70 M -5,89 M -2,55 M
EBITDA — — — —
R&D Expenses 4,05 M 3,62 M 3,52 M 1,49 M
SG&A Expenses — — — —
D&A 290 107,0 — — —
Interest Expense — 100 000,0 2,12 M 917 879,0
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10,48 M 2,51 M 5,95 M 8,65 M
Total Liabilities 8,22 M 1,80 M 1,90 M 975 676,0
Shareholders' Equity 2,25 M 709 152,0 4,06 M 7,68 M
Total Debt — — — 91 021,0
Cash & Equivalents 334 005,0 1,92 M 2,58 M 8,42 M
Current Assets 502 911,0 2,21 M 5,59 M 8,58 M
Current Liabilities 7,97 M 1,53 M 1,04 M 975 676,0